Regeneca Latest To Receive DMAA Warning From FDA

Law360, New York (September 13, 2012, 6:17 PM EDT) -- The U.S. Food and Drug Administration has warned Regeneca Inc. that its weight-loss supplement containing the controversial ingredient DMAA is in violation of federal law, pointing to the same cardiovascular risks that caused the agency to warn 10 other companies about the ingredient earlier this year.

The FDA sent a warning letter to the company regarding its RegeneSlim product on Aug. 28, citing DMAA's tendency to narrow users' blood vessels and arteries, which can lead to shortness of breath and a heart attack. The letter was...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.